Gore Viabil
Payments companies reported to CMS as associated with Gore Viabil. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gore Viabil, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gore Viabil
These are the largest totals companies reported as associated with Gore Viabil. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Douglas Adler | Colorado Springs, CO | Gastroenterology (Internal Medicine) | $21,129.17 |
| Vladimir Kushnir | Saint Louis, MO | Gastroenterology (Internal Medicine) | $11,610.80 |
| Sandeep Patel | San Antonio, TX | Gastroenterology (Internal Medicine) | $6,611.00 |
| Abdul Aadam | Chicago, IL | Gastroenterology (Internal Medicine) | $6,500.00 |
| Salmaan Jawaid | Houston, TX | Gastroenterology (Internal Medicine) | $4,991.28 |
| Anand Kumar | Philadelphia, PA | Gastroenterology (Internal Medicine) | $4,037.50 |
| Amy Hosmer | Pittsburgh, PA | Gastroenterology (Internal Medicine) | $3,990.00 |
| Neil Mehta | Philadelphia, PA | Internal Medicine | $3,706.50 |
| Brian Boulay | Chicago, IL | Gastroenterology (Internal Medicine) | $3,300.00 |
| Sammy Ho | Bronx, NY | Gastroenterology (Internal Medicine) | $1,800.00 |
Prescribed Gore Viabil?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.